Alzamend Neuro, Inc. (ALZN) is listed on NASDAQ in the Manufacturing sector. This page tracks real-time ALZN price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.
Technical Analysis
RSI (14) 67.9 Near Overbought
Market Cap $7.0M
Volume 16.4K
Fundamentals — 10-K FY 2026
Revenue --
Net Income $-8.8M
EPS $-2.63
P/E Ratio -0.6x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Ault Milton C III | Insider | Buy | 108,388 | $1.00 | $108,897 | 2026 Apr 14 |
| Ault Milton C III | Director | Sell | 1,851 | $2.07 | $3,832 | 2025 Dec 23 |
| Horne William B. | Director | Sell | 3,333 | $2.12 | $7,066 | 2025 Dec 19 |
| McGrath Lynne Fahey | Director | Sell | 30 | $2.29 | $69 | 2025 Oct 23 |
| Ault Milton C III | Director | Sell | 121,791 | $2.42 | $294,722 | 2025 Oct 9 |
| Ault Milton C III | Director | Sell | 139,412 | $2.47 | $343,855 | 2025 Oct 7 |
| Ault Milton C III | Director | Sell | 123,366 | $2.40 | $296,669 | 2025 Oct 3 |
| Ault Milton C III | Director | Sell | 79,628 | $2.31 | $184,012 | 2025 Sep 30 |
| Ault Milton C III | Director | Sell | 97,006 | $2.34 | $227,111 | 2025 Sep 25 |
| Ault Milton C III | Director | Sell | 77,009 | $2.35 | $180,971 | 2025 Sep 19 |
| Ault Milton C III | Director | Sell | 22,991 | $2.47 | $56,745 | 2025 Sep 18 |
| Ault Milton C III | Director | Sell | 129,449 | $2.29 | $295,917 | 2025 Jul 31 |
| Ault Milton C III | Director | Sell | 44,843 | $2.86 | $128,216 | 2025 Jul 28 |
| Ault Milton C III | Director | Sell | 69,137 | $2.95 | $203,762 | 2025 Jul 24 |
| Ault Milton C III | Director | Sell | 1,224 | $5.06 | $6,196 | 2025 May 12 |
| Horne William B. | Director | Buy | 3,334 | $0.99 | $3,301 | 2025 Mar 26 |
| Ault Milton C III | Director | Buy | 2,905 | $1.02 | $2,963 | 2025 Mar 21 |
| Katzoff David J | Chief Financial Officer | Buy | 5,000 | $1.01 | $5,050 | 2025 Mar 21 |
| Horne William B. | Director | Buy | 5,000 | $0.98 | $4,900 | 2025 Mar 20 |
| Horne William B. | Director | Buy | 5,000 | $0.97 | $4,850 | 2025 Mar 18 |
Take ALZN further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put ALZN in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Alzamend Neuro, Inc. next reports.
Set alerts on ALZN
Get notified when Alzamend Neuro, Inc. hits your price targets or technical conditions are met.
Get Started Free